The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages

Oncogene

Volumn 32, Issue 5, 2013, Pages 631-640

  Ley, S ^a   Weigert, A ^a   Weichand, B ^a   Henke, N ^a   Mille Baker, B ^b   Janssen, R A J ^c   Brune B ^a  

^a GOETHE UNIVERSITY   (Germany)

^b BioFocus DPI   (United Kingdom)

^c Galapagos BV   (Netherlands)

Author keywords

cancer; immunity; nerve growth factor; sphingolipids; trafficking

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CANCER TISSUE; CELL FUNCTION; CELL ISOLATION; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SUPERNATANT; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; INTERLEUKIN-10; LYSOPHOSPHOLIPIDS; MACROPHAGES; MICE; MICE, TRANSGENIC; NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; SPHINGOSINE;

MURINAE;

EID: 84873414261     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.77     Document Type: Article

References (40)

1. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9: 259 - 270.
2. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39-51.
3. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549 - 555. (Pubitemid 35223554)
4. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008; 66: 1-9. (Pubitemid 351324128)
5. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683 - 765. (Pubitemid 32368050)
6. Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M et al. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 2007; 27: 952 - 964. (Pubitemid 350251222)
7. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10: 170 - 181.
8. Gregory CD, Pound JD. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol 2011; 223: 177 - 194.
9. Hughes JE, Srinivasan S, Lynch KR, Proia RL, Ferdek P, Hedrick CC. Sphingosine-1- phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008; 102: 950 - 958. (Pubitemid 351591554)
10. Weigert A, Tzieply N, von Knethen A, Johann AM, Schmidt H, Geisslinger G et al. Tumor cell apoptosis polarizes macrophages role of sphingosine-1- phosphate. Mol Biol Cell 2007; 18: 3810 - 3819. (Pubitemid 47519475)
11. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008; 8: 753 - 763.
12. Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A et al. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med 2010; 16: 1421 - 1428.
13. Weis N, Weigert A, von Knethen A, Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell 2009; 20: 1280 - 1288.
14. Long JS, Fujiwara Y, Edwards J, Tannahill CL, Tigyi G, Pyne S et al. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J Biol Chem 2010; 285: 35957 - 35966.
15. Toman RE, Payne SG, Watterson KR, Maceyka M, Lee NH, Milstien S et al. Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension. J Cell Biol 2004; 166: 381 - 392. (Pubitemid 39031241)
16. Barra V, Kuhn AM, von Knethen A, Weigert A, Brune B. Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/ CREB. Cell Mol Life Sci 2011; 68: 1815 - 1827.
17. van Es HH, Arts GJ. Biology calls the targets: combining RNAi and disease biology. Drug Discov Today 2005; 10: 1385 - 1391. (Pubitemid 41501793)
18. Jung EJ, Kim CW, Kim DR. Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells. Exp Mol Med 2008; 40: 276 - 285.
19. Arevalo JC, Wu SH. Neurotrophin signaling: many exciting surprises!. Cell Mol Life Sci 2006; 63: 1523 - 1537. (Pubitemid 44156749)
20. Karkoulias G, Flordellis C. Delayed transactivation of the receptor for nerve growth factor is required for sustained signaling and differentiation by alpha2-adrenergic receptors in transfected PC12 cells. Cell Signal 2007; 19: 945 - 957. (Pubitemid 46436435)
21. El Zein N, D'Hondt S, Sariban E. Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation. Cell Signal 2010; 22: 1437 - 1447.
22. Moises T, Dreier A, Flohr S, Esser M, Brauers E, Reiss K et al. Tracking TrkA's trafficking: NGF receptor trafficking controls NGF receptor signaling. Mol Neurobiol 2007; 35: 151 - 159. (Pubitemid 350131692)
23. Weigert A, Cremer S, Schmidt MV, von Knethen A, Angioni C, Geisslinger G et al. Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood 2010; 115: 3531 - 3540.
24. Duong CQ, Bared SM, Abu-Khader A, Buechler C, Schmitz A, Schmitz G. Expression of the lysophospholipid receptor family and investigation of lysophospholipidmediated responses in human macrophages. Biochim Biophys Acta 2004; 1682: 112 - 119. (Pubitemid 38670541)
25. Wetter JA, Revankar C, Hanson BJ. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. J Biomol Screen 2009; 14: 1134 - 1141.
26. Koh E, Clair T, Hermansen R, Bandle RW, Schiffmann E, Roberts DD et al. Sphingosine-1-phosphate initiates rapid retraction of pseudopodia by localized RhoA activation. Cell Signal 2007; 19: 1328 - 1338. (Pubitemid 46561568)
27. Herr B, Zhou J, Werno C, Menrad H, Namgaladze D, Weigert A et al. The supernatant of apoptotic cells causes transcriptional activation of hypoxiainducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. Blood 2009; 114: 2140 - 2148.
28. Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R et al. Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res 2008; 68: 346 - 351. (Pubitemid 351380059)
29. Kruttgen A, Schneider I, Weis J. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol 2006; 16: 304 - 310.
30. Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci USA 1993; 90: 5423 - 5427. (Pubitemid 23176172)
31. Schecterson LC, Bothwell M. Neurotrophin receptors: old friends with new partners. Dev Neurobiol 2010; 70: 332 - 338.
32. Bracci-Laudiero L, Aloe L, Caroleo MC, Buanne P, Costa N, Starace G et al. Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production. Blood 2005; 106: 3507 - 3514. (Pubitemid 41609187)
33. Noga O, Peiser M, Altenahr M, Knieling H, Wanner R, Hanf G et al. Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor. Clin Exp Allergy 2007; 37: 1701 - 1708. (Pubitemid 47609857)
34. Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G et al. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res 2011; 108: 314 - 323.
35. Wang W, Graeler MH, Goetzl EJ. Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J 2005; 19: 1731 - 1733. (Pubitemid 41429545)
36. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008; 8: 618 - 631.
37. Zweifel LS, Kuruvilla R, Ginty DD. Functions and mechanisms of retrograde neurotrophin signalling. Nat Rev Neurosci 2005; 6: 615 - 625. (Pubitemid 41059336)
38. Tsuruda A, Suzuki S, Maekawa T, Oka S. Constitutively active Src facilitates NGFinduced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells. FEBS Lett 2004; 560: 215 - 220. (Pubitemid 38264320)
39. Sandilands E, Akbarzadeh S, Vecchione A, McEwan DG, Frame MC, Heath JK. Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors. EMBO Rep 2007; 8: 1162 - 1169. (Pubitemid 350201735)
40. Bibel M, Hoppe E, Barde YA. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J 1999; 18: 616 - 622. (Pubitemid 29057246)